SCHEMBL7231650

SCHEMBL7231650

CCCC(C[C@@H]1[C@@H](O)[C@H](C(=O)O)C[C@@H]1NC=NN)C(C)CNC(C)=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NEU2 Q9Y3R4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4415958 1.00 NEU2 (0.32) NEU2
SCHEMBL4417831 0.86 — —
SCHEMBL7231029 0.81 NEU2 (0.34) NEU2
SCHEMBL4413704 0.81 NEU2 (0.34) NEU2
SCHEMBL4414561 0.72 — —
SCHEMBL4422850 0.71 — —
SCHEMBL4413595 0.71 — —
SCHEMBL7242472 0.71 — —
SCHEMBL7232829 0.71 — —
SCHEMBL7158053 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562861-B1 (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides BIOCRYST PHARMACEUTICALS, INC. 2003-05-13 — — US claimed
Send feedback